Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
MANTIS logo

MANTIS has been given the greenlight and is now open to recruitment.

 At present, there is little evidence for an effective drug in the treatment of Avascular Necrosis (AVN) of the femoral head. This is an uncommon yet devastating condition, primarily effecting a younger patient population. The MANTIS trial is a blinded, randomised, placebo controlled trial looking at the use of bisphosphonates and whether they can help to delay or prevent the progression of AVN.

 If you would like to be involved as a recruiting site, please contact mantis@ndorms.ox.ac.uk or follow the trial on twitter for the latest news @mantis_trial

Similar stories

AVID-CC trial opens to recruitment!

OCTRU

The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.